What does the evidence say about Tyrosine Cognition Stress Randomized Trial?

Updated October 2026

Quick Answer

Tyrosine Cognition Stress Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: There is mounting evidence that the gut microbiome (GM) and microbial dysbiosis contribute to the common mental health and neurocognitive disorders, including anxiety, bipolar disorder, obsessive‐compulsive disorder, and dementia, via the gut‐brain axis (GBA).

Key Takeaways

  • 01There is mounting evidence that the gut microbiome (GM) and microbial dysbiosis contribute to the common mental health and neurocognitive disorders, including anxiety, bipolar disorder, obsessive‐compulsive disorder, and dementia, via the gut‐brain axis (GBA). [Mandloi Nidhi (2026)]
  • 02In addition, pro‐inflammatory cytokines decrease the serotonin level, which leads to psychological disorders, such as anxiety and depression, and a consequent decrease in the host immunity.Change in GM as a result of consumption of psychobiotics causes a variety of changes, including nervous, endocrine, and immune responses by affecting a person's cognitive, mood, and behavioral reactivity. [Mandloi Nidhi (2026)]
  • 03A placebo‐controlled trial also showed that depressive symptoms significantly improved in thePS128‐treated patients, with the symbiosis of specific microbial taxa.These studies have shown that the GM plays a key role in regulating brain activity and cognition. [Mandloi Nidhi (2026)]
  • 04Over a billion individuals worldwide suffer from mental and addictive disorders, which account for 7% of the global disease burden, and this burden rises as people age.According to the World Mental Health Report, around 1.095 billion people worldwide, approximately one in seven, are afflicted with mental illnesses, indicating a startling burden of mental health issues. [Mandloi Nidhi (2026)]
The current Migaku evidence database contains 2 reusable source documents for Tyrosine Cognition Stress Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - There is mounting evidence that the gut microbiome (GM) and microbial dysbiosis contribute to the common mental health and neurocognitive disorders, including anxiety, bipolar disorder, obsessive‐compulsive disorder, and dementia, via the gut‐brain axis (GBA). [Mandloi Nidhi (2026); evidence level 3] - In addition, pro‐inflammatory cytokines decrease the serotonin level, which leads to psychological disorders, such as anxiety and depression, and a consequent decrease in the host immunity.Change in GM as a result of consumption of psychobiotics causes a variety of changes, including nervous, endocrine, and immune responses by affecting a person's cognitive, mood, and behavioral reactivity. [Mandloi Nidhi (2026); evidence level 3] - A placebo‐controlled trial also showed that depressive symptoms significantly improved in thePS128‐treated patients, with the symbiosis of specific microbial taxa.These studies have shown that the GM plays a key role in regulating brain activity and cognition. [Mandloi Nidhi (2026); evidence level 3] - Over a billion individuals worldwide suffer from mental and addictive disorders, which account for 7% of the global disease burden, and this burden rises as people age.According to the World Mental Health Report, around 1.095 billion people worldwide, approximately one in seven, are afflicted with mental illnesses, indicating a startling burden of mental health issues. [Mandloi Nidhi (2026); evidence level 3] - Importantly, this mechanism primarily reflects acute exercise-related serotonergic responses associated with central fatigue and should not be considered mechanistically equivalent to the chronic serotonergic dysfunction observed in major depressive disorder. [Xu X (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Serotonin neuromicrobiology: Psychobiotic modulation of the gut–brain axis for mental health
  2. Reprogramming brain bioenergetics in depression: an integrative framework linking creatine, branched-chain amino acids, and exercise to neuroplasticity, cognitive function, and depression-related outcomes.